Combined effects of goserelin and tamoxifen on estradiol level, breast density, and endometrial thickness in premenopausal and perimenopausal women with early-stage hormone receptor-positive breast cancer: a randomised controlled clinical trial

BACKGROUND: This study is to investigate the effects of geserelin+tamoxifen (TAM) on estradiol level, breast density (BD), endometrial thickness (ET), and blood lipids in premenopausal and perimenopausal women with hormone receptor-positive early-stage breast cancer. METHODS: This study recruited 11...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yang, H, Zong, X, Yu, Y, Shao, G, Zhang, L, Qian, C, Bian, Y, Xu, X, Sun, W, Meng, X, Ding, X, Chen, D, Zou, D, Xie, S, Zheng, Y, Zhang, J, He, X, Sun, C, Yu, X, Ni, J
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2013
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3738136/
https://ncbi.nlm.nih.gov/pubmed/23860520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.324
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars